Intellectual Property News
13
e Federal Circuit agreed with Arthrex that APJs were
principal ocers. Neither the Secretary nor Director
had the authority to review their decisions or to remove
them at will. e Federal Circuit held that these
restrictions meant that APJs were themselves principal
ocers, not inferior ocers under the direction of the
Secretary or Director.
To x this constitutional violation, the Federal Circuit
invalidated the tenure protections for APJs. Making
APJs removable at will by the Secretary, the panel
held, prospectively “renders them inferior rather than
principal ocers.” e Federal Circuit vacated the
PTAB’s decision and remanded for a fresh hearing
before a new panel of APJs, who would no longer enjoy
protection against removal.
is satised no one. e Government, Smith &
Nephew, and Arthrex each requested rehearing en
banc, which the Court of Appeals denied. e parties
then requested review of dierent aspects of the panel’s
decision in three petitions for certiorari.
We granted those petitions to consider whether the
PTAB’s structure is consistent with the Appointments
Clause, and the appropriate remedy if it is not.
is suit centers on the Patent Trial and Appeal Board
(PTAB), an executive adjudicatory body within the
PTO established by the Leahy-Smith America Invents
Act of 2011. 125 Stat. 313. e PTAB sits in panels of
at least three members drawn from the Director, the
Deputy Director, the Commissioner for Patents, the
Commissioner for Trademarks, and more than 200
Administrative Patent Judges (APJs). 35 U.S.C. §§ 6(a),
(c). e Secretary of Commerce appoints the members
of the PTAB (except for the Director), including the
APJs at issue in this dispute. §§ 3(b)(1), (b)(2)(A),
6(a). Like the 1790 Patent Board, the modern Board
decides whether an invention satises the standards
for patentability on review of decisions by primary
examiners. §§ 6(b)(1), 134(a).
rough a variety of procedures, the PTAB can also
take a second look at patents previously issued by the
PTO. §§ 6(b)(2)–(4). One such procedure is inter
partes review. Established in 2011, inter partes review is
an adversarial process by which members of the PTAB
reconsider whether existing patents satisfy the novelty
and nonobviousness requirements for inventions. See
§ 6(a) of the America Invents Act, 125 Stat. 299. Any
person—other than the patent owner himself—can le
a petition to institute inter partes review of a patent.
35 U.S.C. § 311(a). e Director can institute review
only if, among other requirements, he determines that
the petitioner is reasonably likely to prevail on at least
one challenged patent claim. § 314(a). Congress has
committed the decision to institute inter partes review
to the Director’s unreviewable discretion. See ryv,
Inc. v. Click-To-Call Technologies, LP. By regulation,
the Director has delegated this authority to the PTAB
itself. 37 CFR § 42.4(a) (2020).
e Director designates at least three members of the
PTAB (typically three APJs) to conduct an inter partes
proceeding. 35 U.S.C. § 6(c). e PTAB then assumes
control of the process, which resembles civil litigation
in many respects. § 316(c). e PTAB must issue a nal
written decision on all of the challenged patent claims
within 12 to 18 months of institution. § 316(a)(11);
see SAS Institute Inc. v. Iancu. A party who disagrees
with a decision may request rehearing by the PTAB. 35
U.S.C. § 6(c); 37 CFR § 42.71(d).
e PTAB is the last stop for review within the
Executive Branch. A party dissatised with the nal
decision may seek judicial review in the Court of
Appeals for the Federal Circuit. 35 U.S.C. § 319. At
this stage, the Director can intervene before the court
to defend or disavow the Board’s decision. § 143. e
Federal Circuit reviews the PTAB’s application of
patentability standards de novo and its underlying
factual determinations for substantial evidence. See
Oil States Energy Services, LLC v. Greene’s Energy
Group, LLC. Upon expiration of the time to appeal or
termination of any appeal, “the Director shall issue and
publish a certicate canceling any claim of the patent
nally determined to be unpatentable, conrming
any claim of the patent determined to be patentable,
and incorporating in the patent by operation of the
certicate any new or amended claim determined to be
patentable.” § 318(b).
We hold that the unreviewable authority wielded by
APJs during inter partes review is incompatible with
their appointment by the Secretary to an inferior oce.
e principal dissent repeatedly charges that we never
say whether APJs are principal ocers who were not
appointed in the manner required by the Appointments
Clause, or instead inferior ocers exceeding the
permissible scope of their duties under that Clause.
See post, at 1998 – 1999, 2003, 2006 (opinion of